Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital

NCT06458231 is registered in ClinicalTrials.gov with Port Said University as lead sponsor.

NCT NCT06458231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06458231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Lead sponsor
Port Said University
Phase
Observational
Overall status
Unknown status
Start date
June 25, 2024
Completion date
May 31, 2025
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

central line-associated bloodstream infection (clabsi)